ARAY Accuray Inc.: Accounting Value per Share

Public company logo of Accuray Inc (ARAY)

Accuray Incorporated (ARAY) develops radiotherapy equipment, leveraging multi-year service agreements that ensure a stable FCF at 0.35. Historical price action confirms the business's market positioning. A team of top-tier physicists and engineers is motivated by saving lives, and the company values their expertise. Environmental policy focuses on the safe recycling of electronics and the upgrading of production facilities.

Accuray Inc (ARAY) - Accounting Value per Share from 07/04/2022 to 10/27/2026
Manufactured product of accuray.com

Accuray Incorporated (ARAY) maintains a high status in radiosurgery, and the trust in CyberKnife's precision establishes a basis for assessing the business's intrinsic value through net assets minus liabilities. By analyzing the history of book value per share, an investor determines the fundamental stability of capital and the degree of default protection, comparing the size of equity with the company's potential for operational growth.

Competitor analysis for Accuray Incorporated

BeiGene Corp - Book Value per Share|Halozyme Corp (HALO) - Book Value per Share|Accounting Value per Share RVMD|ascentage.com (AAPG) - Net Asset Value per Share|Book Value per Share CGON|Accounting Value per Share UroGen Pharma Ltd|Book Value per Share BCAX|Book Value per Share PSNL (Personalis Genomics)|ERAS - Net Assets per Single Share|Equity per Share delcath.com DCTH|YMAB: Book Value per Share|AURA - Accounting Value per Share|Book Value per Share CADL|SLS (SELLAS Life Sciences Group) - Net Asset Value per Share|ACTU - Net Assets per Single Share|Accounting Value of a Share citiusonc.com (CTOR)|TuHURA Biosciences, Inc. (HURA) - Accounting Value per Share|Accounting Value of a Share Protara Therapeutics Inc (TARA)|Fate Therapeutics Corp - Book Value per Share|WHWK - Accounting Value per Share|TScan - Accounting Value per Share|CSBR: Book Value per Share|Net Assets per Single Share xbiotech.com XBIT|CEL-SCI (CVM) - Accounting Value of a Share|Book Value per Share OSTX (OS Therapies Inc)|Net Asset Value per Share radiopharmtheranostics.com|Book Value per Share ARTV|Book Value per Share adlainortye.com (ANL)|Veru - Book Value per Share|Accounting Value per Share Tempest Therapeutics Inc TPST|XLO: Book Value per Share|Renovaro Inc. (RENB) - Accounting Value per Share|MURA: Accounting Value per Share|KAPA (Kairos Pharma) - Book Value per Share|OKUR - Net Assets per Single Share|Accounting Value of a Share CytoMed|Book Value per Share CRIS|Book Value per Share apollomicsinc.com APLM|THAR: Accounting Value per Share|ADVB - Net Asset Value per Share|Accounting Value per Share Genprex (GNPX)|CLDI - Accounting Value of a Share|Sunshine Biopharma, Inc. - Book Value per Share|XBIO (Xenetic Biosciences, Inc.) - Net Assets per Share|Net Assets per Single Share Salarius Pharmaceuticals (SLRX)|Equity per Share purple-biotech.com|Book Value per Share AONC (American Oncology Network)|Accounting Value per Share BGNE (BeiGene Ltd.)|CKPT: Net Assets per Single Share|elevationoncology.com - Net Asset Value per Share|Net Assets per Single Share iCAD Corp (ICAD)|IKNA: Accounting Value of a Share|Net Assets per Single Share Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Share Book Value|Net Assets per Single Share MOR (MorphoSys Corp)|Net Asset Value per Share NAYA|Ascentage Pharma Group (AAPGV) - Net Assets per Single Share